Update on therapies for sarcopenia: novel approaches for age-related muscle wasting and weakness

By Lynch Gordon S  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 9, 2004-09 ,pp. : 1329-1344

Informa Healthcare

Access to resources Recommend Favorite

Novel, effective protocol for muscular dystrophy

By  

Inpharma, Vol. 1, Iss. 1399, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Deflazacort helps to maintain both muscle and pulmonary function in Duchenne muscular dystrophy

By  

Inpharma, Vol. 1, Iss. 1275, 2001-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Gene expression profiling to monitor therapeutic and adverse effects of antisense therapies for Duchenne muscular dystrophy

By ’t Hoen Peter AC   van der Wees Caroline GC   Aartsma-Rus Annemieke   Turk Rolf   Goyenvalle Aurélie   Danos Olivier   Garcia Luis   van Ommen Gert-Jan B   den Dunnen Johan T   van Deutekom Judith CT  

Pharmacogenomics, Vol. 7, Iss. 3, 2006-04 ,pp. : 281-297

Future Medicine

Access to resources Recommend Favorite

Gene Replacement Therapies for Duchenne Muscular Dystrophy Using Adeno-Associated Viral Vectors

By  

Current Gene Therapy, Vol. 12, Iss. 3, 2012-06 ,pp. : 139-151

Bentham Science Publishers

Access to resources Recommend Favorite